Exelixis (EXEL) Gross Margin Growth (1y) (2013 - 2026)

Exelixis (EXEL) Gross Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 18.00

Historic Data

Download Data
DateValue
Apr 3, 2026 18.00
Jan 2, 2026 -90.00
Oct 3, 2025 10.00
Jul 4, 2025 -65.00
Apr 4, 2025 155.00
Jan 3, 2025 101.00
Sep 27, 2024 77.00
Jun 28, 2024 100.00
Mar 29, 2024 -150.00
Dec 29, 2023 -78.00
Sep 29, 2023 -26.00
Jun 30, 2023 -55.00
Mar 31, 2023 21.00
Sep 30, 2022 -10.00
Jul 1, 2022 65.00
Apr 1, 2022 118.00
Oct 1, 2021 16.00
Jul 2, 2021 -31.00
Apr 2, 2021 -79.00
Oct 2, 2020 -100.00